S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead
S&P 500   5,061.82
DOW   37,735.11
QQQ   431.06
5 Small-Cap Energy Stocks Surged in Price and Volume on Friday
Novo Nordisk Arms Wegovy to Be a Triple Threat
Vital Farms Rides the Pasture-Raised Egg Trend to the Bank
3 Energy Plays for Cash Flow: Buy 1 or Buy Them All
M&T Bank, Goldman Sachs rise; Salesforce, Tesla fall, Monday, 4/15/2024
When Will the Next Bull Market Be?
Global smartphone shipments climb nearly 8% in 1st quarter as Samsung retakes the lead

G1 Therapeutics (GTHX) Insider Trading & Ownership

$4.31
-0.24 (-5.27%)
(As of 04/15/2024 ET)

G1 Therapeutics (NASDAQ:GTHX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
8.23%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
5
Amount Of
Insider Selling
(Last 12 Months)
$397,880.45
Get GTHX Insider Trade Alerts

Want to know when executives and insiders are buying or selling G1 Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

GTHX Insider Buying and Selling by Quarter

G1 Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/18/2024John W V UmsteadCFOSell6,547$3.02$19,771.94  
2/12/2024Rajesh MalikInsiderSell28,600$4.62$132,132.00  
1/4/2024John W V UmsteadCFOSell111$2.94$326.34  
1/4/2024Terry L MurdockCOOSell721$2.94$2,119.74  
1/3/2024Rajesh MalikInsiderSell3,019$3.12$9,419.28  
1/2/2024John E (Jack) Jr. BaileyCEOSell32,983$3.27$107,854.41  
12/11/2023Rajesh MalikInsiderSell33,839$3.41$115,390.99  
7/5/2023Andrew PerryInsiderSell355$2.45$869.75  
7/5/2023John E (Jack) Jr. BaileyCEOSell2,719$2.45$6,661.55  
7/5/2023Terry L MurdockCOOSell1,361$2.45$3,334.45  
(Data available from 1/1/2013 forward)

GTHX Insider Trading Activity - Frequently Asked Questions

Who is on G1 Therapeutics's Insider Roster?

The list of insiders at G1 Therapeutics includes Andrew Perry, James S Hanson, Jennifer K Moses, John E (Jack) Jr. Bailey, John W V Umstead, Mark A Velleca, Rajesh Malik, and Terry L Murdock. Learn more on insiders at GTHX.

What percentage of G1 Therapeutics stock is owned by insiders?

8.23% of G1 Therapeutics stock is owned by insiders. Learn more on GTHX's insider holdings.

Which G1 Therapeutics insiders have been selling company stock?

The following insiders have sold GTHX shares in the last 24 months: Andrew Perry ($5,445.35), Jennifer K Moses ($9,145.62), John E (Jack) Jr. Bailey ($301,827.11), John W V Umstead ($20,098.28), Mark A Velleca ($1,456,700.00), Rajesh Malik ($539,722.27), and Terry L Murdock ($12,748.24).

How much insider selling is happening at G1 Therapeutics?

Insiders have sold a total of 279,110 G1 Therapeutics shares in the last 24 months for a total of $2,345,686.87 sold.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:GTHX) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners